Last10K.com

Cme Group Inc. (CME) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, December 31, 2013

Cme Group Inc.

CIK: 1156375 Ticker: CME





Exhibit 99.1
 
 
 
Media contact
Investor contact
 
Anita Liskey, 312.466.4613
John Peschier, 312.930.8491
 
William Parke, 312.930.3467
CME-G
 
news@cmegroup.com
 
 
www.cmegroup.mediaroom.com
 
FOR IMMEDIATE RELEASE
CME Group Inc. Reports Fourth-Quarter 2013 Financial Results
CHICAGO, February 4, 2014 — CME Group Inc. (NASDAQ: CME) today reported revenues of
$687 million and operating income of $323 million for the fourth quarter of 2013. Net income attributable to CME Group was $193 million and diluted earnings per share was $0.58. Excluding the items noted in the reconciliation, adjusted earnings per share would have been $0.64.1 

“This was a year of progress,” said CME Group Executive Chairman and President Terry Duffy.  “Throughout 2013 we faced many challenges as we worked with regulators and industry participants to successfully navigate the three waves of the Dodd-Frank clearing mandate.  Our response to a dynamically changing landscape inside and outside the U.S. has been exceptional.  In addition, the economy showed signs of incremental improvement and the Federal Reserve began taking steps to reduce quantitative easing.  We have been successful at not only building our own business for the future, but also in contributing to the regulatory process and laying the groundwork for our customers to move their businesses forward under the new and evolving market structure debate.”

“I am very pleased with fourth-quarter results, highlighted by double-digit average daily volume growth in our futures and options complex when compared with last year,” said CME Group Chief Executive Officer Phupinder Gill.  “This strong performance was driven by a 29 percent increase in interest rate volume.  Innovative new interest rate futures and options product extensions launched in the last few years represented 4 percent of the total interest rate volume in the fourth quarter.  The new year is off to a good start, with increased volatility in interest rate, equity, and energy markets resulting in an increase of 13 percent in average daily volume in January.  Looking ahead, we will continue to build on the most extensive product offering available today to deliver innovative solutions to meet our customers' needs.”



1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to Non-GAAP Measures chart at the end of the financial statements.
- more -



The following information was filed by Cme Group Inc. (CME) on Tuesday, February 4, 2014 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Cme Group Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cme Group Inc..

Continue

Assess how Cme Group Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cme Group Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Consolidated Balance Sheets
Consolidated Balance Sheets Balance Sheet Parenthicals
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Consolidated Statements Of Shareholders' Equity
Consolidated Statements Of Shareholders' Equity Equity Statement Parentheticals
Dei Statement
Accumulated Other Comprehensive Income (loss)
Accumulated Other Comprehensive Income (loss) (schedule Of Accumulated Other Comprehensive Income) (details)
Accumulated Other Comprehensive Income (loss) (tables)
Capital Stock
Capital Stock (capital Stock) (details)
Capital Stock (narrative) (details)
Capital Stock (tables)
Commitments
Commitments (narrative) (details)
Commitments (non-cancelable Operating Leases And Contractual Obligations) (details)
Commitments (tables)
Contingencies
Contingencies (details)
Debt
Debt (fair Value Of Fixed Rate Notes By Maturity Date) (details)
Debt (long-term Debt Maturities At Par Value) (details)
Debt (narrative) (details)
Debt (schedule Of Short-term And Long-term Debt) (details)
Debt (tables)
Derivative Instruments
Derivative Instruments (effect Of Derivative Instruments On The Statements Of Income And Shareholders' Equity) (details)
Derivative Instruments (narrative) (details)
Derivative Instruments (tables)
Derivative Instruments Fair Value Of Derivatives By Balance Sheet Location (details)
Earnings Per Share
Earnings Per Share (basic And Diluted Earnings Per Share) (details)
Earnings Per Share (tables)
Employee Benefit Plans
Employee Benefit Plans (accumulated Other Comprehensive Income (loss), Of The Prior Service Costs And Actuarial Losses) (details)
Employee Benefit Plans (anticipated Benefit Payments From The Plan In Future Years) (details)
Employee Benefit Plans (asset Allocation For The Plan) (details)
Employee Benefit Plans (change In Plan Assets) (details)
Employee Benefit Plans (components Of Net Pension Expense) (details)
Employee Benefit Plans (fair Value Of Plan Assets) (details)
Employee Benefit Plans (narrative) (details)
Employee Benefit Plans (summary Of The Change In Projected Benefit Obligation) (details)
Employee Benefit Plans (tables)
Employee Benefit Plans (target Allocation Percentages) (details)
Fair Value Measurements
Fair Value Measurements (financial Instruments Measured At Fair Value On A Recurring Basis) (details)
Fair Value Measurements (narrative) (details)
Fair Value Measurements (reconciliation Using Significant Unobservable Inputs) (details)
Fair Value Measurements (tables)
Guarantees
Guarantees (details)
Income Taxes
Income Taxes (deferred Tax Assets (liabilities) ) (details)
Income Taxes (federal Income Tax Rate) (details)
Income Taxes (income Tax Provision) (details)
Income Taxes (reconciliation Of Unrecognized Tax Benefits) (details)
Income Taxes (summary Of Unrecognized Tax Benefits) (details)
Income Taxes (tables)
Income Taxes Income Taxes (narrative) (details)
Intangible Assets And Goodwill
Intangible Assets And Goodwill (components Of Intangible Assets) (details)
Intangible Assets And Goodwill (future Estimated Amortization Expense) (details)
Intangible Assets And Goodwill (goodwill Activity) (details)
Intangible Assets And Goodwill (narrative) (details)
Intangible Assets And Goodwill (tables)
Intangible Assets And Goodwill Intangible Assets And Goodwill (useful Lives Of Intangible Assets) (details)
Long-term Investments
Long-term Investments (details)
Marketable Securities
Marketable Securities (amortized Cost And Fair Value Of Marketable Securities) (details)
Marketable Securities (available-for-sale Securities) (details)
Marketable Securities (narrative) (details)
Marketable Securities (tables)
Organization And Business
Organization And Business (details)
Performance Bonds And Guaranty Fund Contributions
Performance Bonds And Guaranty Fund Contributions (cash And Securities Held As Performance Bonds And Guaranty Fund Contributions At Fair Value) (details)
Performance Bonds And Guaranty Fund Contributions (narrative) (details)
Performance Bonds And Guaranty Fund Contributions (performance Bond Deposits And Security Deposits) (details)
Performance Bonds And Guaranty Fund Contributions (tables)
Property
Property (details)
Property (tables)
Quarterly Information (unaudited)
Quarterly Information (unaudited) (details)
Quarterly Information (unaudited) (tables)
Redeemable Non-controlling Interest
Redeemable Non-controlling Interest (details)
Redeemable Non-controlling Interest (tables)
Schedule Ii—valuation And Qualifying Accounts
Schedule Ii—valuation And Qualifying Accounts Schedule Ii—valuation And Qualifying Accounts (details)
Stock-based Payments
Stock-based Payments (compensation Expense And Income Tax Benefit Recognized) (details)
Stock-based Payments (narrative) (details)
Stock-based Payments (restricted Stock Activity) (details)
Stock-based Payments (stock Option Activity) (details)
Stock-based Payments (tables)
Subsequent Events
Subsequent Events (details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (narrative) (details)
Summary Of Significant Accounting Policies (policy)
Ticker: CME
CIK: 1156375
Form Type: 10-K Annual Report
Accession Number: 0001156375-14-000012
Submitted to the SEC: Fri Feb 28 2014 6:30:52 PM EST
Accepted by the SEC: Mon Mar 03 2014
Period: Tuesday, December 31, 2013
Industry: Security And Commodity Brokers Dealers Exchanges And Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cme/0001156375-14-000012.htm